Inicio・Lista de Acciones・Novartis AG

Novartis AG

Cerrado

160.28 3.45

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

154.22

Máximo

160.78

Métricas clave
By Trading Economics
Ingresos	110M 3.3B
Ventas	894M 14B
P/B Media del Sector	22.784 57.371
BPA	2.41
Rentabilidad por dividendo	3.12
Margen de beneficios	22.654
Empleados	75,267
EBITDA	526M 5.9B

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+2.88% upside

Dividendos
By Acuity
Rentabilidad por dividendo Media del Sector	3.12% 2.23%

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	3.5B 289B
Apertura anterior	156.83
Cierre anterior	160.28

Novartis AG Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

18 ago 2026, 23:56 UTC

Correlated Moves

Hecla Mining Co shares are lower in after-market trading, pressured by declining silver prices and rising sovereign bond yields amid inflation concerns.

18 ago 2026, 23:56 UTC

Huntington Ingalls Industries shares are higher in after-market trading, reflecting strength above its 20-day moving average and near the upper end of its one-month range.

18 ago 2026, 23:56 UTC

News

Exelixis shares are lower in after-market hours following BMO's Market Perform rating. Broader market pressures from rising bond yields also weigh on the stock.

18 ago 2026, 23:56 UTC

American Water Works shares are higher in after-market trading, despite rising sovereign bond yields impacting investor sentiment across equities.

18 ago 2026, 23:56 UTC

Coursera Inc shares are higher in after-market trading, despite no specific news driving the movement. Broader market conditions reflect rising sovereign bond yields.

18 ago 2026, 23:56 UTC

Correlated Moves

Social Media

The iShares Core U.S. Aggregate Bond ETF rose slightly in after-market trading, reflecting recent fluctuations in the 10-year yield and broader market sentiment.

18 ago 2026, 23:56 UTC

Steel Dynamics Inc shares are trading lower in after-market hours, remaining below the 20-day moving average amid ongoing market weakness. No specific news was identified.

18 ago 2026, 23:56 UTC

Chipotle Mexican Grill Inc shares are higher in after-market trading, reflecting a modest increase since Tuesday's close amid rising sovereign bond yields.

18 ago 2026, 23:56 UTC

Array Technologies Inc shares are higher in after-market trading, reflecting a modest gain since Tuesday's close. The stock remains below its 20-day moving average.

18 ago 2026, 23:56 UTC

News

Carvana Co's shares are higher in after-market trading amid concerns over major shareholder Mark Walter's federal investigation and potential stake sale valued at $2 billion.

18 ago 2026, 23:56 UTC

Correlated Moves

Vicor Corp shares are lower in after-hours trading amid broader market volatility and concerns over rising bond yields and geopolitical tensions.

18 ago 2026, 23:56 UTC

VF Corp shares are higher in after-market trading following a recovery from an earlier decline. The price remains below its 20-day moving average.

18 ago 2026, 23:56 UTC

Fastenal Co shares are higher in after-market trading, maintaining performance above the 20-day moving average despite concerns over rising sovereign bond yields.

18 ago 2026, 23:56 UTC

Paccar Inc shares rose in after-market trading, despite no specific news. The stock remains below its 20-day moving average amid broader market pressures.

18 ago 2026, 23:56 UTC

Correlated Moves

Morgan Stanley shares are lower in after-market trading amid unusual volatility and rising bond yields, which are pressuring equities and growth prospects.

18 ago 2026, 23:56 UTC

Social Media

Johnson & Johnson returns the C-CAR039 program to AbelZeta, while discussions about a potential acquisition of Legend Biotech continue. Shares are roughly flat in after-market trading.

18 ago 2026, 23:56 UTC

Correlated Moves

Campbell Soup Co shares are higher in after-market trading, advancing since Tuesday's close and positioning above the 20-day moving average.

18 ago 2026, 23:56 UTC

Upbound Group Inc shares are higher in after-market hours, recovering from three consecutive lower closes, though still below the 20-day moving average.

18 ago 2026, 23:56 UTC

CEVA Inc. shares gained in after-market trading, reaching a high above Tuesday's close, though they remain below their 20-day moving average.

18 ago 2026, 23:56 UTC

Coca-Cola Co's shares are higher in after-market trading, reflecting a modest increase since Tuesday's close. The stock remains above its 20-day moving average.

18 ago 2026, 23:52 UTC

News

Social Media

IONQ partners with CMC Microsystems to enhance cloud quantum computing access in Canada. Shares are lower in after-market hours following the announcement.

18 ago 2026, 23:51 UTC

Agilent Technologies Inc shares declined in after-market hours amid broader market concerns over rising bond yields and inflation linked to geopolitical tensions.

18 ago 2026, 23:51 UTC

Genpact Ltd shares are lower in after-market hours amid concerns over elevated bond yields and inflation, despite initial gains earlier in the session.

18 ago 2026, 23:51 UTC

Northrop Grumman shares are higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month range.

18 ago 2026, 23:51 UTC

Correlated Moves

Lennox International Inc shares are higher in after-market trading, reflecting broader trends in correlated assets like Toll Brothers Inc amid rising bond yields.

18 ago 2026, 23:51 UTC

Correlated Moves

Pultegroup Inc shares are lower in after-market hours, following declines in the Russell 2000 Index and rising concerns over elevated bond yields.

18 ago 2026, 23:51 UTC

Correlated Moves

Ichor Holdings Ltd shares are lower in after-market hours, influenced by a decline in the Nasdaq 100 Index and rising bond yields.

18 ago 2026, 23:51 UTC

Monday.Com Ltd. shares declined after-market amid concerns over rising bond yields and inflation. The stock remains above its 20-day moving average.

18 ago 2026, 23:51 UTC

Cardinal Health Inc. shares are lower in after-market trading, maintaining declines amid broader market concerns over elevated bond yields and inflation linked to geopolitical tensions.

18 ago 2026, 23:51 UTC

Correlated Moves

Lam Research shares declined in after-market trading, influenced by rising bond yields and broader market trends, including a slight drop in the Nasdaq 100 Index.

Comparación entre iguales

Cambio de precio

Novartis AG previsión

Precio Objetivo

By TipRanks

2.88% repunte

Estimación a 12 Meses

Media 159 USD 2.88%

Máximo 180 USD

Mínimo 139 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novartis AG Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Novartis AG Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.